Strength of TCR-peptide/MHC interactions and in vivo T cell responses

Journal of Immunology

Volumn 186, Issue 9, 2011, Pages 5039-5045

  Corse, Emily ^a   Gottschalk, Rachel A ^a,b   Allison, James P ^a,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Weill Graduate School of Medical Sciences of Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BINDING AFFINITY; CANCER IMMUNIZATION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; CELL INTERACTION; CELL MANIPULATION; COMPLEX FORMATION; CYTOKINE PRODUCTION; DISEASE FREE SURVIVAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG RECEPTOR BINDING; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; LISTERIA MONOCYTOGENES; LOW DRUG DOSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 79955541353     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003650     Document Type: Short Survey

References (80)

1. Germain, R. N., and I. Stefanová. 1999. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu. Rev. Immunol. 17: 467-522.
2. Davis, M. M., M. Krogsgaard, J. B. Huppa, C. Sumen, M. A. Purbhoo, D. J. Irvine, L. C. Wu, and L. Ehrlich. 2003. Dynamics of cell surface molecules during T cell recognition. Annu. Rev. Biochem. 72: 717-742.
3. van der Merwe, P. A., and O. Dushek. 2011. Mechanisms for T cell receptor triggering. Nat. Rev. Immunol. 11: 47-55.
4. Kung, P., G. Goldstein, E. L. Reinherz, and S. F. Schlossman. 1979. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206: 347-349.
5. Van Wauwe, J. P., J. R. De Mey, and J. G. Goossens. 1980. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J. Immunol. 124: 2708-2713.
6. Graber, M., L. K. Bockenstedt, and A. Weiss. 1991. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number. J. Immunol. 146: 2935-2943.
7. Abraham, R. T., and A. Weiss. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308.
8. Schwartz, R. H. 1985. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3: 237-261.
9. Kisielow, P., H. Blüthmann, U. D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333: 742-746.
10. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
11. Savage, P. A., J. J. Boniface, and M. M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10: 485-492.
12. Krogsgaard, M., N. Prado, E. J. Adams, X. L. He, D. C. Chow, D. B. Wilson, K. C. Garcia, and M. M. Davis. 2003. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 12: 1367-1378.
13. Huseby, E. S., F. Crawford, J. White, P. Marrack, and J. W. Kappler. 2006. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Nat. Immunol. 7: 1191-1199.
14. Janetzki, S., C. M. Britten, M. Kalos, H. I. Levitsky, H. T. Maecker, C. J. Melief, L. J. Old, P. Romero, A. Hoos, and M. M. Davis. 2009. "MIATA"-minimal information about T cell assays. Immunity 31: 527-528.
15. Davis, M. M., J. J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16: 523-544.
16. McKeithan, T. W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92: 5042-5046.
17. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9: 817-826.
18. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.
19. Stone, J. D., A. S. Chervin, and D. M. Kranz. 2009. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 126: 165-176.
20. Germain, R. N. 2010. Computational analysis of T cell receptor signaling and ligand discrimination - past, present, and future. FEBS Lett. 584: 4814-4822.
21. Kalergis, A. M., N. Boucheron, M. A. Doucey, E. Palmieri, E. C. Goyarts, Z. Vegh, I. F. Luescher, and S. G. Nathenson. 2001. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2: 229-234.
22. Krogsgaard, M., and M. M. Davis. 2005. How T cells 'see' antigen. Nat. Immunol. 6: 239-245.
23. McMahan, R. H., J. A. McWilliams, K. R. Jordan, S. W. Dow, D. B. Wilson, and J. E. Slansky. 2006. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J. Clin. Invest. 116: 2543-2551.
24. Tian, S., R. Maile, E. J. Collins, and J. A. Frelinger. 2007. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J. Immunol. 179: 2952-2960.
25. Aleksic, M., O. Dushek, H. Zhang, E. Shenderov, J. L. Chen, V. Cerundolo, D. Coombs, and P. A. van der Merwe. 2010. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity 32: 163-174.
26. Dustin, M. L., D. E. Golan, D. M. Zhu, J. M. Miller, W. Meier, E. A. Davies, and P. A. van der Merwe. 1997. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 272: 30889-30898.
27. Qi, S., M. Krogsgaard, M. M. Davis, and A. K. Chakraborty. 2006. Molecular flexibility can influence the stimulatory ability of receptor-ligand interactions at cell-cell junctions. Proc. Natl. Acad. Sci. USA 103: 4416-4421.
28. Dustin, M. L., and C. Zhu. 2006. T cells like a firm molecular handshake. Proc. Natl. Acad. Sci. USA 103: 4335-4336.
29. Huppa, J. B., M. Axmann, M. A. Mörtelmaier, B. F. Lillemeier, E. W. Newell, M. Brameshuber, L. O. Klein, G. J. Schütz, and M. M. Davis. 2010. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463: 963-967.
30. Huang, J., V. I. Zarnitsyna, B. Liu, L. J. Edwards, N. Jiang, B. D. Evavold, and C. Zhu. 2010. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature 464: 932-936.
31. Wülfing, C., J. D. Rabinowitz, C. Beeson, M. D. Sjaastad, H. M. McConnell, and M. M. Davis. 1997. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 185: 1815-1825.
32. Rosette, C., G. Werlen, M. A. Daniels, P. O. Holman, S. M. Alam, P. J. Travers, N. R. Gascoigne, E. Palmer, and S. C. Jameson. 2001. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15: 59-70.
33. Chen, J. L., A. J. Morgan, G. Stewart-Jones, D. Shepherd, G. Bossi, L. Wooldridge, S. L. Hutchinson, A. K. Sewell, G. M. Griffiths, P. A. van der Merwe, et al. 2010. Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor. J. Immunol. 184: 1829-1839.
34. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction - a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
35. Cemerski, S., J. Das, J. Locasale, P. Arnold, E. Giurisato, M. A. Markiewicz, D. Fremont, P. M. Allen, A. K. Chakraborty, and A. S. Shaw. 2007. The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse. Immunity 26: 345-355.
36. Tailor, P., S. Tsai, A. Shameli, P. Serra, J. Wang, S. Robbins, M. Nagata, A. L. Szymczak-Workman, D. A. Vignali, and P. Santamaria. 2008. The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling. J. Immunol. 181: 243-255.
37. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
38. Adachi, K., and M. M. Davis. 2011. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells. Proc. Natl. Acad. Sci. USA 108: 1549-1554.
39. Huppa, J. B., M. Gleimer, C. Sumen, and M. M. Davis. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4: 749-755.
40. Gottschalk, R. A., E. Corse, and J. P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207: 1701-1711.
41. von Andrian, U. H., and T. R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
42. Celli, S., Z. Garcia, H. Beuneu, and P. Bousso. 2008. Decoding the dynamics of T cell-dendritic cell interactions in vivo. Immunol. Rev. 221: 182-187.
43. Bousso, P., and E. Robey. 2003. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4: 579-585.
44. Henrickson, S. E., T. R. Mempel, I. B. Mazo, B. Liu, M. N. Artyomov, H. Zheng, A. Peixoto, M. P. Flynn, B. Senman, T. Junt, et al. 2008. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat. Immunol. 9: 282-291.
45. Obst, R., H. M. van Santen, D. Mathis, and C. Benoist. 2005. Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J. Exp. Med. 201: 1555-1565.
46. Valitutti, S., S. Müller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375: 148-151.
47. Prlic, M., G. Hernandez-Hoyos, and M. J. Bevan. 2006. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med. 203: 2135-2143.
48. Fahmy, T. M., J. G. Bieler, M. Edidin, and J. P. Schneck. 2001. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 14: 135-143.
49. Xiao, Z., M. F. Mescher, and S. C. Jameson. 2007. Detuning CD8 T cells: downregulation of CD8 expression, tetramer binding, and response during CTL activation. J. Exp. Med. 204: 2667-2677.
50. Busch, D. H., and E. G. Pamer. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189: 701-710.
51. Amrani, A., J. Verdaguer, P. Serra, S. Tafuro, R. Tan, and P. Santamaria. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406: 739-742.
52. Malherbe, L., C. Hausl, L. Teyton, and M. G. McHeyzer-Williams. 2004. Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity 21: 669-679.
53. Fazilleau, N., L. J. McHeyzer-Williams, H. Rosen, and M. G. McHeyzer-Williams. 2009. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10: 375-384.
54. Rees, W., J. Bender, T. K. Teague, R. M. Kedl, F. Crawford, P. Marrack, and J. Kappler. 1999. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96: 9781-9786.
55. Anderton, S. M., C. G. Radu, P. A. Lowrey, E. S. Ward, and D. C. Wraith. 2001. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193: 1-11.
56. Williams, M. A., E. V. Ravkov, and M. J. Bevan. 2008. Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity 28: 533-545.
57. Slifka, M. K., and J. L. Whitton. 2001. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2: 711-717.
58. Jameson, S. C., F. R. Carbone, and M. J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177: 1541-1550.
59. Jenkins, M. R., A. Tsun, J. C. Stinchcombe, and G. M. Griffiths. 2009. The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse. Immunity 31: 621-631.
60. Wherry, E. J., K. A. Puorro, A. Porgador, and L. C. Eisenlohr. 1999. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163: 3735-3745.
61. Wherry, E. J., M. J. McElhaugh, and L. C. Eisenlohr. 2002. Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope. J. Immunol. 168: 4455-4461.
62. Leignadier, J., and N. Labrecque. 2010. Epitope density influences CD8+ memory T cell differentiation. PLoS ONE 5: e13740.
63. Obar, J. J., and L. Lefrançois. 2010. Memory CD8+ T cell differentiation. Ann. N. Y. Acad. Sci. 1183: 251-266.
64. Teixeiro, E., M. A. Daniels, S. E. Hamilton, A. G. Schrum, R. Bragado, S. C. Jameson, and E. Palmer. 2009. Different T cell receptor signals determine CD8+ memory versus effector development. Science 323: 502-505.
65. Zehn, D., S. Y. Lee, and M. J. Bevan. 2009. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458: 211-214.
66. Corse, E., R. A. Gottschalk, M. Krogsgaard, and J. P. Allison. 2010. Attenuated T cell responses to a high-potency ligand in vivo. PLoS Biol. 8: e1000481.
67. Zhu, J., and W. E. Paul. 2010. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 238: 247-262.
68. Tao, X., C. Grant, S. Constant, and K. Bottomly. 1997. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding. J. Immunol. 158: 4237-4244. (Pubitemid 127483924)
69. Rogers, P. R., and M. Croft. 1999. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J. Immunol. 163: 1205-1213. (Pubitemid 29352735)
70. Constant, S., C. Pfeiffer, A. Woodard, T. Pasqualini, and K. Bottomly. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182: 1591-1596.
71. Jorritsma, P. J., J. L. Brogdon, and K. Bottomly. 2003. Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J. Immunol. 170: 2427-2434. (Pubitemid 36245630)
72. Yamane, H., J. Zhu, and W. E. Paul. 2005. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 202: 793-804.
73. Milner, J. D., N. Fazilleau, M. McHeyzer-Williams, and W. Paul. 2010. Cutting edge: lack of high affinity competition for peptide in polyclonal CD4+ responses unmasks IL-4 production. J. Immunol. 184: 6569-6573.
74. Thorstenson, K. M., and A. Khoruts. 2001. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195. (Pubitemid 32567777)
75. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
76. Turner, M. S., L. P. Kane, and P. A. Morel. 2009. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J. Immunol. 183: 4895-4903.
77. Skokos, D., G. Shakhar, R. Varma, J. C. Waite, T. O. Cameron, R. L. Lindquist, T. Schwickert, M. C. Nussenzweig, and M. L. Dustin. 2007. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat. Immunol. 8: 835-844.
78. Singh, N. J., and R. H. Schwartz. 2003. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J. Exp. Med. 198: 1107-1117.
79. Han, S., A. Asoyan, H. Rabenstein, N. Nakano, and R. Obst. 2010. Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery. Proc. Natl. Acad. Sci. USA 107: 20453-20458.
80. Sadegh-Nasseri, S., S. K. Dalai, L. C. Korb Ferris, and S. Mirshahidi. 2010. Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy. Immunology 129: 1-7.